Xeris Biopharma Holdings Inc. – Indentures Watch

from S-3 40 pages Xeris Biopharma Holdings, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities

from S-8 1 page Amendment to Xeris Pharmaceuticals, Inc. Inducement Equity Plan

from 8-K 78 pages Indenture or similar

from 10-K 36 pages Indenture or similar

from 10-K 12 pages � � � ���������� � ������ �!�����!��"�#$�%$�&'()*+,(�-.�/0(�12))23/4� � �� 5�6� 7�8���98��7����!��:7���� ��7��"�;�8<� ��7���=9 8��� �!!��5��!!��68���=9 898�76�!���!����!9�!�>�?��@a B � C� D�758�9 7�7�57�8��!�!��:7�6���57�!��e�7��� 89���=9 8�!��95�f5����>�g�95 7�8�8�59�!�"�6� 57�8��!��!7�h���i� ���=9 8�7� 8��7�!��=9 8$��ab�jk� �l�5�!�6��� 55��"�%�!��!�9i�m5�!�"��6���>�g���7�!�5���!���:7�98���m��59!�"� 7n5 ���9�m5�f5���m5�!����!�8� �!���6�7�857�!����� �!!�!��=9 8��5��!!��68���=9 8�98�766��� 8�9 7�7�57�o�!�>�!6�5��7�� 89���=9 8�!�95�f5����9�m5�!��"�95 7�8�8��59�!�"�6� 57��@o9�p5g89�?95d�8��!��!7�h���i� ���=9 8�7� 8���7�!�=9 8���m��=9 8��5���:7��59�!�"�9 57�56��!6�!95<� Q R S�?�t�u?� <�� Q R �59�!�"���57���:7� � � �� S R �59�!�"��� 57�� !7�� 6 �;�!�� �o�!�>� � � �� ? R �!�9i�m5�!��v78�"���7�!�5�5� � � �� U R �>�g��7w57���7�!�5�5���9�m5�!��v78"� X� 5 �!��5�m��!�9i�m5�!��"���797��!<� �!��v78�"��77��8�5�6��f57���7�597�mnn5�9i��!�9i�m5���797����m6�!��6� �m���;y�76z8� 7�76�!m�[�76�z8�!��7�!�5e��!��8�9��v78�"���7��8�5�6��f57���7597�mnn5�9i��!�9i�m5�!�v78�"���� � �v78�"��=9 8�57��!9��6�58���5�9 8��7�!�v78�"�7�8�=9 8�!9�5\7�5�557�v78�"��797��67�!�8��u7�!�z�5�=9 8��9�5w���]6\�����!�9i�m5�!��v78�"��797���� ��m5�m7�8��7�!��=9 8h�v78�"� 55��5]6\$���

from 10-K 19 pages � �� ��� ��� �� �� �� ���� � � ���� ��� ����� !�"�#$!% &!'(� � � � �� �����) (� �*� ���+ ,� � �� ��� ��� �-���� �. � ���� ��/ � (��* � � � (� 0� � �1���� � ���� ��� 2� �!�3&&4!�#$!% &!5�6��� ��+ � ��/�7(��� � 1�8���/ �� �� �. ��� ����� �*(��) � ��� 8�� ��/ (� 9�� � 8(�-���8���+ � ��� ���+ �� �� ���+ ��� ��� � �� �� ���� � � � �*�� � � � �:�� ��� �� ��� ��� �-���� �8���/ � ���� �/ �� ��: �;�. � '(��* � � � (� 0� � �1���� ���� ��� (��*�8�� �����) �� ��/ � ��*� < ��� =� >� ?��@�a� �� �� �� � ���+ <����� =� >� B� ��/ ��� ���) ��� �� ��?� >� B� ��/ ��� �� �� �c����:�� ��� �� ��� >� B� � 1�8���d �/ ��� ������ �� ��a� >� B� �. �� E ��� ������ �8���d �/ �� F � ����8(�� � 1�8���/ ��� ��*<� ���d �/ � � ��� �� �- ��� � �8 99 � 1(� � 1�8��� ����8 ���� �8 ���cg�b �h� � �8�i�b H� �� ��,� � ���� ��d �/ � �� ��� �� �- ��� � �8 99 � 1(�� � 1�8��d �/ ���� � �d �/ �*�� � �� �*� ��� � � � � �d �/ � ��� (� � J �� �d / (�� �� ����a ��h (��� �� �e���k J(��*�� � 1�8���d �/ ��� ���� � �8� 8 ��� ��� 0�d / � ���k J2� F � � (�� ������ ��) � ��� ��:�� 2�l%mnop�qmr'� � ��*� ���d �/ � � ��b�: -�s�/�t 1� ���d �/ � ��� �b�: -�s�/�t 1(��� � �u2/2�� � � ���*��d �/ � �� ( ���d �/ � ��� ���u2/2�� � � �(��� � � 1��*��d / � �� 2�6��d �/ � ��� � � (�b �h'� ��A�H2�V4&O!&&�QMR'� �� ���/ (��/ � �� ��*��f �k 8�a1��:*�? 1�� J � � - ��*� �8� �� �� 2� 7

from 10-K 17 pages Indenture or similar

from 10-Q 15 pages Form of Warrant to Purchase Common Stock

from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities and Exchange Act of 1934, as Amended

from S-3 40 pages Xeris Biopharma Holdings, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities

from S-3 2 pages Indenture or similar

from S-3 2 pages Indenture or similar

from 8-K 20 pages Common Stock Purchase Warrant Xeris Biopharma Holdings, Inc

from 8-K12B 6 pages Second Supplemental Indenture

from 8-K12B 68 pages Xeris Pharmaceuticals, Inc. and U.S. Bank National Association as Trustee First Supplemental Indenture Dated as of June 30, 2020 5.00% Convertible Senior Notes Due 2025

from 8-K12B 40 pages Xeris Pharmaceuticals, Inc., Issuer and U.S. Bank National Association, Trustee Indenture Dated as of June 30, 2020 Senior Debt Securities